| Name | Disodium (2-{2-[(E)-(2,5-disulfophenyl)diazenyl]-4-formyl-5-hydroxy-6-methyl-3-pyridinyl}ethyl)phosphonate |
|---|---|
| Synonyms |
1,4-Benzenedisulfonic acid, 2-[(E)-2-[4-formyl-5-hydroxy-6-methyl-3-(2-phosphonoethyl)-2-pyridinyl]diazenyl]-, sodium salt (1:2)
Disodium (2-{2-[(E)-(2,5-disulfophenyl)diazenyl]-4-formyl-5-hydroxy-6-methyl-3-pyridinyl}ethyl)phosphonate |
| Description | Iso-PPADS tetrasodium is a P2X-purinoceptor antagonist. Iso-PPADS tetrasodium inhibits P2X1 and P2X3 receptor with IC50s of 43 nM and 84 nM. Iso-PPADS tetrasodium is protective against ventilator-induced brain injury (VIBI)[1][2]. |
|---|---|
| Related Catalog | |
| Target |
43 nM and 84 nM (P2X1 and P2X3 receptor)[2] |
| References |
| Molecular Formula | C14H10N3Na4O12PS2 |
|---|---|
| Molecular Weight | 599.30 |
| Exact Mass | 552.960266 |